Filter
1130
Text search:
landscape
Featured
76
275
Language
Document type
503
325
112
74
63
21
11
9
8
3
1
Countries / Regions
77
35
26
24
23
22
20
19
18
18
15
15
14
14
13
13
12
12
12
12
12
11
11
10
10
10
10
10
9
9
8
7
7
7
7
6
5
5
5
5
5
5
4
4
3
3
3
3
3
3
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Authors & Publishers
Publication Years
Category
360
64
61
54
43
19
12
Toolboxes
131
110
100
45
42
42
37
37
34
31
30
30
27
18
17
17
14
13
9
7
6
3
2
1
1
Semi-annual Update
Report V of Conversations on Planetary Health
The tab is the result of a preliminary landscape of vaccines licensed or under development for Mpox
The tab is the result of a preliminary landscape of therapeutics licensed or under development for Mpox
Accessed November, 2017
J of Pharm Policy and Pract 14, 27 (2021). https://doi.org/10.1186/s40545-021-00309-8
Nutrition data and information systems (ND&IS) are critical to guide the prioritisation, collection, analysis and
dissemination of nutrition data in countries. However, there is limited guidance for countries regarding how to invest
in their ND&IS and little is known about current financing alloca
...
The report presents current information (updated to September 2015) on candidate vaccines, therapies and medical devices for Ebola and gives an overview of completed and on-going trials.
Practically, planetary health presents a new way to approach and solve problems. For example, there is
alignment at the highest levels with global policy frameworks – primarily the Convention on Biological
Diversity Aichi Biodiversity Targets, the Paris Climate Agreement, and the Sustainable Dev
...
Malar J (2017) 16:174 DOI 10.1186/s12936-017-1808-x
Background: Since 2004, artemisinin-based combination therapy (ACT) has been the first-line treatment for uncomplicated malaria in Benin. In 2016, a medicine outlet survey was implemented to investigate the availability, price, and market share of
...
Interim Guidance October 2022. This addendum addresses some of the methodological aspects of VE evaluations that have been learned during the past year, as well as those that have become relevant in the current epidemiological setting of the COVID-19 pandemic. For some of the COVID-19 vaccine method
...
ALTER, European Journal of Disability Research 9(2015)317–330.
The purpose of this paper is to describe the varying scope and content of data collection instruments on child disability and to provide a historical snapshot of the rates of reported disability among children. A total of 716 data sou
...
Many vaccines and drugs hold the promise of reducing mortality and morbidity among pregnant women and infants living in low- and middle-income countries (LMICs). However, sufficient information on the safety of drugs and vaccines in pregnant women is rarely available at the time of product licensure
...
A systematic review of clinical and observational antiparasitic treatment studies to assess the potential for establishing an individual participant-level data platform.
Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations s
...
Chagas disease (CD), caused by the parasite Trypanosoma cruzi, affects ~6–7 million people worldwide. Significant limitations still exist in our understanding of CD. Harnessing individual participant data (IPD) from studies could support more in-depth analyses to address
the many outstanding rese
...
#AIDS2016 | @AIDS_conference
Accessed: 26.09.2019
